PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
35.86
+0.43 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
35.89
+0.03 (0.08%)
After-hours: Dec 5, 2025, 7:09 PM EST
PROCEPT BioRobotics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for PROCEPT BioRobotics stock have an average target of 56.57, with a low estimate of 50 and a high estimate of 84. The average target predicts an increase of 57.75% from the current stock price of 35.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PROCEPT BioRobotics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 8 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $56 → $51 | Buy | Maintains | $56 → $51 | +42.22% | Dec 2, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $85 → $50 | Strong Buy | Maintains | $85 → $50 | +39.43% | Nov 5, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $55 → $50 | Buy | Reiterates | $55 → $50 | +39.43% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $58 → $51 | Buy | Maintains | $58 → $51 | +42.22% | Nov 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $64 → $50 | Strong Buy | Maintains | $64 → $50 | +39.43% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
333.01M
from 224.50M
Increased by 48.34%
Revenue Next Year
430.76M
from 333.01M
Increased by 29.35%
EPS This Year
-1.54
from -1.75
EPS Next Year
-1.17
from -1.54
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 355.4M | 454.7M | ||||
| Avg | 333.0M | 430.8M | ||||
| Low | 318.0M | 406.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 58.3% | 36.5% | ||||
| Avg | 48.3% | 29.4% | ||||
| Low | 41.6% | 22.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.54 | -0.55 | ||||
| Avg | -1.54 | -1.17 | ||||
| Low | -1.51 | -1.50 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.